DICE develops innovative oral medicines for chronic autoimmune and inflammatory diseases. They combine chemistry with biology to make medicines more accessible and unlock the potential of oral medicines. The team is led by experienced scientists and executives with a track record of progressing programs from discovery to commercialization. They have a passion for innovation and extensive experience in small molecule drug discovery and development.